Upgrade to SI Premium - Free Trial

TD Cowen Downgrades Novo Nordisk (NVO) to Hold

March 10, 2026 3:00 AM
TD Cowen analyst Michael Nedelcovych downgraded Novo Nordisk (NYSE: NVO) from Buy to Hold with a price target of $42.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Downgrades